Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about the unregistered sales of equity securities.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The disclosures provided in Item 1.01 are also included in this section as mandated by Form 8-K requirements.
For further insights into DNTH stock, check out TipRanks’ Stock Analysis page.